Larazotide
Tight junction regulatory peptide that reduces intestinal permeability. Studied for celiac disease and gut barrier dysfunction associated with leaky gut and inflammatory bowel conditions.
0 anonymous reports
Also known as:
at-1001larazotide acetatetight junction peptide
browse topics:
No reports found.
Community Q&A
- What does larazotide do for gut health?
- Community accounts describe larazotide as a gut barrier restoration compound — acting on tight junctions to reduce the permeability that allows food proteins and bacteria to cross the gut wall inappropriately. Accounts come primarily from people with celiac disease, NCGS (non-celiac gluten sensitivity), and inflammatory bowel conditions. The most commonly described effect: reduced symptomatic reaction to accidental gluten exposure and improved overall gut stability over 4–8 week protocols.
- Is larazotide better than BPC-157 for gut healing?
- Community accounts describe the two as addressing different mechanisms. BPC-157 accounts emphasise tissue repair and regeneration — healing damaged gut wall. Larazotide accounts emphasise barrier function — preventing inappropriate permeability regardless of inflammation state. Accounts from users with celiac disease specifically cite larazotide as more targeted for their condition. BPC-157 remains more prevalent in gut healing confessions overall by community volume.